In August 2001, cerivastatin was removed from European and USA markets because of a higher risk of rhabdomyolysis associated with its use in comparison with other statins. The objective of this study was to compare cholesterol-lowering drug use in Italy before and after the withdrawal of cerivastatin from the market, and to evaluate if the withdrawal influenced patients compliance and physicians prescribing habits. After August 2001, 48% of cerivastatin users discontinued any statin treatment. The major risk factor for discontinuation was a concomitant use of fibrate during the first 7 months of 2001 (OR = 2.3; 95% CI = -2.9). Comparing the discontinuation of statin therapy between 2001 and 2000 we can estimate that there was a 5% increase, corresponding to about 200,000 patients, who discontinued statin therapy during autumn 2001 because of cerivastatin emergency.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healthpol.2004.04.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rising global burden of anxiety disorders among adolescents and young adults: trends, risk factors, and the impact of socioeconomic disparities and COVID-19 from 1990 to 2021.
Front Psychiatry
November 2024
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
Background: Anxiety disorders are among the most prevalent mental health conditions globally, particularly affecting adolescents and young adults (10-24 years), and causing substantial psychological and social impairments. This study analyzed changes in the incidence, prevalence, and disability-adjusted life years (DALYs) of anxiety disorders in this age group from 1990 to 2021, emphasizing the impact of socioeconomic disparities and the COVID-19 pandemic, particularly post-2019.
Methods: Utilizing the Global Burden of Disease(GBD) 2021 data from 204 countries, this study evaluated global trends in anxiety disorders among adolescents and young adults.
Experiences of participation in daily life of adolescents and young adults with cerebral palsy: A scoping review.
Dev Med Child Neurol
December 2024
Neurodisability & Rehabilitation, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Aim: To synthesize the experiences of 15- to 34-year-olds with cerebral palsy (CP) as they participate in key life situations of young adulthood.
Method: A mixed-methods scoping review was undertaken and six electronic databases searched (January 2001 to August 2023). Participation foci and thematic outcomes were mapped to the International Classification of Functioning, Disability and Health.
Associations of smoke-free policies in multi-unit housing with smoking behavior and second-hand smoke exposure: A systematic review.
Addiction
December 2024
Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY, USA.
Background And Aim: Although considerable progress has been made regarding the implementation of smoke-free policies (SFPs), many people continue to be exposed to second-hand smoke (SHS) in the home environment. The aim of this study was to conduct a systematic review on the association of SFPs in multi-unit housing (MUH) with smoking behavior and SHS exposure.
Methods: In August 2022, we searched five online databases: PubMed, Embase, Web of Science, PsycINFO and CENTRAL.
Rare but elevated incidence of hematological malignancy after clozapine use in schizophrenia: A population cohort study.
PLoS Med
December 2024
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR.
Background: Clozapine is widely regarded as a highly efficacious psychotropic drug that is largely underused worldwide. Recent disproportionality analyses and nationwide case-control studies suggested a potential association between clozapine use and hematological malignancy (HM). Nevertheless, the absolute rate difference is not well-established due to the absence of analytic cohort studies.
View Article and Find Full Text PDFElucidating epigenetic landscape of gastric premalignant lesions through genome-wide mapping of 5-hydroxymethylcytosines: A 12-year median follow-up study.
Clin Transl Med
December 2024
Department of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Article Synopsis
- The study investigates the role of 5-hydroxymethylcytosines (5hmC) in the progression of gastric premalignant lesions to gastric adenocarcinoma (GAC) in a large cohort of Chinese patients, with data collected over 12.2 years.
- Researchers conducted a genome-wide mapping of 5hmC that revealed 213 differentially modified gene bodies tied to important biological pathways like cell division, metabolism, and tumorigenesis.
- A predictive model based on 5hmC demonstrated strong potential for assessing cancer progression risk, achieving an 87.5% accuracy in validation samples, marking a significant advance in understanding gastric cancer development.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!